Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Institute of Medicine Pushes PEPFAR on Data Collection, Disclosure

The Institute of Medicine, the prestigious health arm of the National Academy of Sciences, has weighed in with a massive report on the President’s Emergency Plan for AIDS Relief (PEPFAR), the multibillion dollar US effort to confront the epidemic in the developing world. The evaluation validates PEPFAR’s enormous reach during its first 10 years and identifies concrete actions that Congress and PEPFAR should take for the program to become more sustainable moving forward.

Improving PEPFAR’s Data Management and Disclosure

The US government spends about $6.4 billion a year on preventing and treating HIV/AIDS in the developing world, and 4.5 million AIDS patients depend mostly on US generosity each day for the AIDS medicines that keep them alive.

AIDS Spending a Good Investment? Maybe Not

Video of the debate may be viewed here.

Yesterday was an exciting day for me. In a debate at the World Bank timed to coincide with the International AIDS Conference a colleague and I took an unpopular position against two development celebrities in front of a potentially hostile audience and changed some minds. The proposition was:

“Continued AIDS investment by donors and governments is a sound investment, even in a resource constrained environment”

Will Donors Embrace Global "Entitlements" for Health Care And Other Basic Human Needs?

Gorik Ooms and European colleagues are organizing a small meeting in Brussels in October to be called the Global Responsibilities for Global Health Rights Conference. The Conference is organized by the Helene De Beir Foundation and has the moral or financial support of AIDS Fonds, Netherlands; Parliamentarians for the MDGs, Belgium; International Centre for Reproductive Health, Belgium; International Civil Society Support, Netherlands; Institute of Tropical Medicine, Antwerp, Belgium and The Lancet, United Kingdom.